Cancer Informatics represents a hybrid discipline encompassing the fields of oncology, computer science, bioinformatics, statistics, computational biology, genomics, proteomics, metabolomics, pharmacology, and quantitative epidemiology. The common bond or challenge that unifies the various disciplines is the need to bring order to the massive amounts of data generated by researchers and clinicians attempting to find the underlying causes and effective means of treating cancer.
T he focus of bioinformatics in cancer research has shifted from generating ranked lists of genes associated with a particular clinical outcome to systematic analysis of critical signaling pathways and molecular networks in pathogenesis (1;2). This Supplement Issue of Cancer Informatics introduces cutting-edge computational methods developed for pathway and network-based analysis of cancer susceptibility and metastasis, including integrative regulatory networks of DNA copy number and expression profiles (3;4), co-expression network analysis of lncRNAs (5) and E2F-responsive genes (6), modeling the Notch signaling pathway in colon cancer therapy (7), functional genomic analysis in cancer prognosis (8), dysregulated pathways (9), and microRNA profiling of induced pluripotent stem (iPS) cells (10). As pointed out in the comprehensive review of molecular network analysis provided in this Supplement Issue (11), the future directions of systematic analysis of cancer susceptibility and metastasis are to utilize multi-level molecular profiles and to combine different computational methods in the analysis, in order to dissect important biological pathways and network modules in cancer initiation and progression. 
